# Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Males

> **NCT01544673** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Gram Positive Infection

## Interventions

- **DRUG:** linezolid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01544673
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01544673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01544673, "Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Males". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01544673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*